Latest news and updates about the Medicare and pharmacy industries.

June 21: Pharma Companies Sue to Oppose Listing Drug Prices in TV Ads

Posted on in Industry Updates by Amplicare Team

Plus, the latest pharmacy and healthcare news to know this week.

The Story

Last Friday, Amgen, Merck, Eli Lilly, and the Association of National Advertisers filed a lawsuit against the Trump administration, opposing a new regulation mandating that list prices of prescription drugs appear in direct-to-consumer TV ads. The new rule implemented by the Department of Health and Human Services (HHS) is set to take effect in July.

Why it Matters

The rule requires that television ads for prescription drugs covered by Medicare or Medicaid include the Wholesale Acquisition Cost if it is equal to or greater than $35 for a month’s fill or regular course of therapy. This is part of the HHS’ efforts to lower the cost of drugs and make the market more competitive. Supporters of the regulation believe that this move toward transparency will ensure that patients are not kept in the dark about the cost of their healthcare and will be able to make more informed decisions.

On the other hand, pharma companies critical of this new regulation argue that there is a discrepancy between the list price and the final price consumers pay. List prices may be much higher, as they don’t account for possible discounts and rebates pharmaceuticals provide. Simply revealing a list price also does not take into consideration differences between insurances, treatments, and patients. According to Amgen, the new rule fails to address a patient’s main concern: how much the medicine will cost them in the end.

With pharma companies pushing against the government’s efforts, it is uncertain whether this controversial regulation will actually have the chance to make a difference in costs.

More healthcare news to watch:

1. Rite Aid’s new partnership with Adobe aims to better the patient’s health and wellness experience. Forbes.

2. As prescription drug prices increase, one in 10 Americans skip doses to save money. CBS.

3. Fraud schemes involving genetic testing have been targeting Medicare beneficiaries. Tulsa World.

4. Last Monday, pharmacy organizations issued a letter to President Trump supporting DIR fee reform. Drug Topics.

5. In New York, a proposed legislation putting the state in control of negotiating prescription drug prices for Medicaid patients could lower costs and keep local pharmacies in business. AM New York.

Other Articles

Posted on by Amplicare Team

October 18: CMS Releases 2020 Star Ratings for MA, Part D Plans

Medicare Open Enrollment has begun, CMS releases new Star Ratings for 2020, pharmacist prescribing is on the rise, and...
Continue Reading

Posted on by Amplicare Team

Listen: 3 Pharmacists Share Their Secrets for Medicare Open Enrollment Success

Pharmacists Liz Altmiller, Bob Hinkle, and Chris Cornelison, share tips for increasing pharmacy profitability during Medicare Open Enrollment.
Continue Reading

Posted on by Amplicare Team

October 11: CDC Finds Low Vaccination Rates for Pregnant Women

The majority of soon-to-be mothers in the U.S. do not receive flu and Tdap vaccinations, the U.S. wastes billions...
Continue Reading

Posted on by Amplicare Team

September 27: Premiums Decline for Medicare Advantage and Part D plans

Medicare Advantage premiums in 2020 will decrease by 23% compared to 2018, and more healthcare news to know this...
Continue Reading